Healthy Skepticism Library item: 5695

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: news

Organon claims Tolvon has “similar levels of efficacy as amitripyline, imipramine and clomipramine, but is associated with significantly less side-effects” and is “similar in efficacy and side-effects to the newer anti-depressants with which it has been compared”
MaLAM Australian News 1993 Sep

Abstract:

Organon promotes Tolvon (mianserin) as being as effective as tricyclic antidepressants and newer antidepressants and safer than the tricyclics. These claims are not necessarily substantiated by the scientific literature.

Keywords:
*analysis/Australia/developed countries/mianserin/Tolvon/Organon/safety & risk information/efficacy/ psychotropic drugs/MaLAM/Medical Lobby for Appropriate Marketing/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPED COUNTRIES/PROMOTION IN SPECIFIC THERAPEUTIC AREAS: PSYCHIATRIC DISEASES